Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Cancer Res. 2019 Sep 11;26(3):537–544. doi: 10.1158/1078-0432.CCR-19-2138

Table 2.

Anti-KRAS T-cell receptors isolated from patients with metastatic cancer treated in the Surgery Branch at the NCI in Bethesda, MD.

KRAS
Mutation
Patient # Cancer
Diagnosis
CD4/CD8 HLA-
Restriction
Method
G12D 4095
4238
Colon
Colon
CD8
CD4
C*08:02 (8%)
Class II (DR)
TMG
IVS
G12V 4148 Endometrial CD4
CD8
DRB1*07:01 (25%)
A*11:01 (14%)
TMG
IVS
G12C 4173 Ovarian CD4 DRB1*11:01 (10%) IVS
G12R 4268 Colon CD4 Class II TMG